| Bioactivity | Ritivixibat is an inhibitor of ileal bile acid transporter (IBAT), as well as a bile acid modulator. Ritivixibat can be used for research of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases[1][2]. |
| Name | Ritivixibat |
| CAS | 2460667-52-9 |
| Formula | C26H36N2O5S2 |
| Molar Mass | 520.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gillberg Per-Goeran, et al. Preparation of benzothiazepines as liver bile acid transport inhibitors for the treatment of liver, gastrointestinal and other disorders: United States, US20200247769. 2020-08-06. [2]. WHO Drug Information-World Health Organization (WHO). |
Ritivixibat
CAS: 2460667-52-9 F: C26H36N2O5S2 W: 520.70
Ritivixibat is an inhibitor of ileal bile acid transporter (IBAT), as well as a bile acid modulator. Ritivixibat can be
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.